4//SEC Filing
Allouche Cyril 4
Accession 0001479290-18-000121
CIK 0001479290other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:30 PM ET
Size
4.6 KB
Accession
0001479290-18-000121
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Sale
Common Stock
2018-11-20$20.66/sh−491$10,144→ 4,000 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Allouche.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001744573
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:30 PM ET
- Size
- 4.6 KB